Acetylcysteine Injection, Solution
NDC Package 83270-001-04
Package Information
Acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in adults and pediatric patients who weigh 5 kg or greater with acute ingestion or from repeated supratherapeutic ingestion (RSI). This formulation utilizes a injection, solution delivery system. Marketed by Onesource Specialty Pharma Limited, this product is identified by NDC 83270-001 and is authorized under FDA application ANDA217182.
Identification & Billing
- RxCUI: 465377 - acetylcysteine 6 GM in 30 ML Injection
- RxCUI: 465377 - 30 ML acetylcysteine 200 MG/ML Injection
- RxCUI: 465377 - acetylcysteine 6 GM per 30 ML Injection
Clinical Specifications
- Antidote - [EPC] (Established Pharmacologic Class)
- Antidote for Acetaminophen Overdose - [EPC] (Established Pharmacologic Class)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Increased Glutathione Concentration - [PE] (Physiologic Effect)
- Mucolytic - [EPC] (Established Pharmacologic Class)
- Reduction Activity - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 83270 - Onesource Specialty Pharma Limited
- 83270-001 - Acetylcysteine
- 83270-001-04 - 4 VIAL, SINGLE-DOSE in 1 CARTON / 30 mL in 1 VIAL, SINGLE-DOSE (83270-001-01)
- 83270-001 - Acetylcysteine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83270-001-04 identifies a specific commercial package of 4 vial, single-dose in 1 carton / 30 ml in 1 vial, single-dose (83270-001-01) of Acetylcysteine, a human prescription drug labeled by Onesource Specialty Pharma Limited. This injection, solution is formulated for intravenous use and contains acetylcysteine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Onesource Specialty Pharma Limited on April 26, 2023. The current certification is valid through December 31, 2027.
How is this Onesource Specialty Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83270000104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.